What's in Seiji Umemoto, M.D., Ph.D.'s pipeline?

Seiji Umemoto, M.D., Ph.D. has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Seiji Umemoto, M.D., Ph.D.'s portfolio?

Top competitors by shared drug class: Bristol-Myers Squibb, Cedars-Sinai Medical Center, National University of Ireland, Galway, Ireland, Novartis, Takeda.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/seiji-umemoto-m-d-ph-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Seiji Umemoto, M.D., Ph.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Seiji Umemoto, M.D., Ph.D. pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Angiotensin receptor blockers	Angiotensin receptor blockers	marketed
β-blockers	β-blockers	marketed
thiazide diuretics	thiazide diuretics	marketed	Thiazide diuretic	Sodium-chloride cotransporter (NCC)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bristol-Myers Squibb · 1 shared drug class
Cedars-Sinai Medical Center · 1 shared drug class
National University of Ireland, Galway, Ireland · 1 shared drug class
Novartis · 1 shared drug class
Takeda · 1 shared drug class
University of Virginia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Seiji Umemoto, M.D., Ph.D.:

Cite this brief

Drug Landscape (2026). Seiji Umemoto, M.D., Ph.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/seiji-umemoto-m-d-ph-d. Accessed 2026-05-16.